This announcement is a separate document:
华东医药：浙江天册律师事务所关于华东医药股份有限公司2022限制性股票激励计划预留授予限制性股票第一个解除限售期解除限售条件成就之法律意见书
Huadong Pharmaceutical: Legal Opinion of Zhejiang Tianze Law Firm on the 2022 Restricted Stock Incentive Plan of Huadong Pharmaceutical Co., Ltd. reserves and grants restricted stocks the first time to lift sales restrictions during the sales restriction period and the achievement of lifting the sales restrictions
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated